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Abstract
In dentistry, biomaterials are used in restorative procedures, such as dental 
restorations; in dentures; dental implants; surgical procedures; and endodontic 
materials. Most dental biomaterials are classified as devices, including filling 
materials, diagnostic aids, cements, bonding agents, and implants, in addition to 
mouthwashes. In the field of health, the use of natural products for dental bioma-
terials and curing diseases has always emphasized, rather than depending on the 
conventional allopathic medicine. Brazil has an advantage in this market, because it 
has the greatest biodiversity in the world, especially in the Amazonian Region, and 
a genetic heritage of great potential for the development of new herbal products, 
especially in dentistry. Given the growth of products derived from medicinal plants 
in Brazil, it was necessary to implement a statute that covered the requirements 
for all medicines and biomaterials to ensure the quality, efficacy, and safety of 
these products. Thus, researches in dentistry have been developed with the aim of 
searching for new bioactive principles for the formulation of drugs with different 
types of applications, capable of acting in both preventive strategies and curative 
treatments. This has encouraged the use of phytotherapic agents such as Copaifera 
multijuga, Apis mellifera (propolis), and Libidibia ferrea.
Keywords: medicinal plants, Copaifera multijuga, Apis mellifera, Libidibia ferrea, 
dentin surface, orabase, mouthwash
1. Introduction
According to the American National Institute of Health (NIH), biomaterial is 
defined as “any substance or combination of substances, other than drugs, synthetic 
or natural in origin, which can be used for any period of time, which augments or 
replaces partially or totally any tissue, organ or function of the body, in order to 
maintain or improve the quality of life of the individual” [1]. The advances led to 
a pronounced increase in the range of use and efficacy of biomaterials over time. 
Thus, biomaterials have become critical components used in many industries, 
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including medical devices, dental restoratives, and drug delivery, and are increas-
ingly being used in technological applications such as in vitro diagnostics [2, 3].
These materials must be biocompatible at the material-tissue interface: “ability 
of a biomaterial to perform its desired function with respect to a medical therapy, 
without eliciting any undesirable local or systemic effects in the recipient or benefi-
ciary of that therapy, but generating the most appropriate beneficial cellular or tissue 
response to that specific situation” [1]. In dentistry, biomaterials are used in restor-
ative procedures, such as dental restorations; dentures; dental implants; surgical pro-
cedures; and endodontic materials. Most dental biomaterials are classified as devices, 
including filling materials, diagnostic aids, cements, bonding agents, and implants 
[1, 4, 5]. In addition, commercial mouthwashes are used as antiseptics for better oral 
hygiene. Therapeutic mouthwashes reduce bacterial counts, have antiplaque effects, 
work as an astringent, and help to reduce gingivitis and carious lesions [6, 7].
Dental materials should not be toxic, irritant, or corrosive and should be easy to 
use. The biomaterials used in dentistry can be metals (amalgam of silver, titanium, 
and gold), ceramics (feldspar, alumina, zirconia, porcelain reinforced with silica), 
composites [1], materials that can optimize dentin bonding, and mouthwashes. 
However, in the field of health, the use of natural products for dental biomateri-
als and curing of diseases has always emphasized, rather than depending on the 
conventional allopathic medicine [7].
Following this trend, in addition to the devices and materials themselves, bio-
logical advances have revolutionized the methods used in the chemical and material 
industries to produce and transform raw materials. Living plants can be processed 
in large quantities to produce a much larger variety of liquids and materials, without 
the cost of energy or effluent streams—typical by-products of the chemical indus-
try. Nature is not only capable of allowing the synthesis of new chemical substances 
but also significantly reducing the costs and environmental impacts associated with 
the manufacture of current chemicals and drugs [3].
In 1978, the World Health Organization (WHO) recognized medicinal plants as a 
therapeutic resource [8]. The Ordinance No. 971 dated May 03, 2006, approved the 
National Policy on Integrative and Complementary Practices (PNPIC) in the Unified 
Health System (SUS) in Brazil, including the use of phytotherapy [9]. At present, phy-
totherapy is defined as a science-based practice for the treatment of diseases, which 
uses medicinal plants, plant drugs, and preparations, not including substances from 
another source [10]. Therefore, biomaterials made today are routinely information rich 
and incorporate biologically active components derived from nature [2, 3, 5, 7]. Today, 
the variety of natural products used in the biomaterials for dental and oral health 
care may include natural silk [11], propolis [12–15], chitosan [16], herbal tea [17], and 
miswak [18], as well as natural products for bone repair such as dolomite [4].
Since phytotherapy is a feasible method for the control and prevention of the 
development of oral pathologies, with the additional possibility of incorporating 
phyto-derived compounds into biomaterials, the discovery of new phytotherapic 
compounds has been of high relevance to dentistry [5, 14, 19–22]. Brazil has an 
advantage in this market because it has the greatest biodiversity in the world, 
especially in the Amazo nian Region, and a genetic heritage of great potential 
for the development of new herbal products [23], especially in dentistry. Given 
the growth of products derived from medicinal plants in Brazil, it was necessary 
to implement a statute that covered the requirements for all medicines and/or 
biomaterials to ensure the quality, efficacy, and safety of these products. In this 
sense, the Brazilian National Health Surveillance Agency (ANVISA) establishes 
product quality control requirements, involving stages ranging from obtaining of 
raw materials through to the qualitative and quantitative characterization of their 
active principles [24, 25].
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The official recognition of phytotherapy in dentistry in Brazil was accompanied 
by several gaps in scientific research on medicinal plants, specifically for plant spe-
cies with applications in diseases of the oral cavity. The state of Amazonas, specifi-
cally the city of Manaus, did not have a diagnosis of the applicability of medicinal 
plants in dental services. In this sense, these researchers conducted an ethnobotani-
cal study to identify the main plants used for pathogenesis of the oral cavity, with 
the aim of reducing their empirical use and favoring the use of medicinal plants 
based on scientific evidence [10].
The search for the biomaterials, their development, and pharmaceutical forms 
comprises products derived from medicinal plants with compounds that are safe 
and have proven quality. Thus, researches in dentistry have been developed with 
the objective of searching for new bioactive principles for the formulation of drugs 
with different types of applications, capable of acting in both preventive strategies 
and curative treatments, thus encouraging the use of phytotherapic agents such as 
Copaifera multijuga, Apis mellifera (propolis), and Libidibia ferrea.
2. Copaifera multijuga—copaiba oil
According to the growing interest in antimicrobial agents derived from medicinal 
plants, natural products are considered an excellent alternative to synthetic chemi-
cals. Amazonian biodiversity products that have been used for years in folk medicine 
have emerged as feasible and promising alternatives for inhibiting microorganisms 
in dental biofilm. Copaiba oil—as it is popularly called—a phytotherapeutic agent 
widely used by the Amazonian population, is known for its antibacterial, anti-
inflammatory, anesthetic healing and antitumoral medicinal properties.
The studies developed with copaiba oil have complied with all the norms 
required. The Copaifera multijuga Hayne species were collected from official 
research institutions (National Research Institute of Amazonian—INPA) to guar-
antee the legitimacy of the species. The exsiccata was stored in the INPA Herbarium 
under No. 270709.
2.1 Antibacterial activity of copaiba oil formulations
The first reports demonstrated the use of copaiba oil as an effective agent 
against the etiological agents of caries disease, as seen in Ref. [26]. This research 
demonstrated the antibacterial activity of calcium hydroxide and zinc oxide pastes 
associated with essential oil and C. multijuga resin against Streptococcus mutans. 
The bacteriostatic and bactericidal activities of the oil in natura against the same 
microorganism were also reported, giving rise to a line of research in dentistry in 
the search of scientific evidence.
C. multijuga Hayne has presented promising antibacterial activity against S. 
mutans, S. mitis, S. salivarius, S. constellatus, and S. sanguinis from the copaiba gel 
production for the dental biofilm control [27]. In addition, evidence was shown of 
antibacterial activity against Enterococcus faecalis and Candida albicans present in 
endodontic flora, biological compatibility test in the teeth of rats and dogs using 
the copaiba oil as vehicle for calcium hydroxide [26], biological compatibility test 
in gingival tissue and a physical-chemical study and antibacterial activity dental 
cement to suit the conditions of the oral environment [28], and antibacterial activ-
ity in copaiba oil emulsions, as shown in Table 1 [22].
The results of the chromatographic analysis of C. multijuga oil revealed that the 
structures of its components are made up of various sesquiterpenes, primarily being 
constituted of β-caryophyllene and its oxide, forming its biological activity [26–28]. 
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Figure 1. 
Effect of copaiba oil on metalloproteinase (MMP) activity (gelatin zymography).
In [29], a high proportion of sesquiterpenes (88.55–98.05%) was revealed in the 
copaiba oils analyzed, with β-caryophyllene being the main type.
2.2 Copaiba oil emulsion as dentin biomodifier
Different approaches have been proposed to improve the restorative material 
bond to the dental structure by optimizing the infiltration of resinous monomers into 
the demineralized dentin and reduce the rate of water absorption and collagen deg-
radation, by means of such as the application of an additional layer or multiple layers 
of a hydrophobic adhesive agent [30], vigorous solvent evaporation [31], polymeriza-
tion, and the use of electric current to improve impregnation of the monomers [32].
Metalloproteinases (MMPs) trapped in the extracellular matrix are calcium-
dependent and zinc-activated enzymes that mediate the denaturation of the 
extracellular matrix through collagenase (MMP-8 is the major collagenase in human 
dentin) and gelatinase (MMP-2 and MMP-9), as well as the enamelysin MMP-20 
and the stromelysin MMP-3, which are naturally entrapped in the mineralized 
dentin during odontogenesis [33]. Since the bonding process occurs as a result of 
encapsulation of the collagen by the adhesive system, it is necessary to inhibit these 
enzymes to preserve the adhesive interface from proteolytic and hydrolytic degra-
dation, by forming the hybrid layer [34].
Tested copaiba 
emulsions
MIC of the copaiba emulsions (μL/mL) against the bacteria
S. mutans  
(μL/mL)
S. oralis  
(μL/mL)
S. salivarius  
(μL/mL)
L. casei  
(μL/mL)
Emulsion 10% 12.5 12.5 12.5 12.5
Emulsion 10% + PB 1%
Emulsion 30% 37.5 37.5 37.5 37.5
Emulsion 30% + PB 1%
Table 1. 
Minimum inhibitory concentration (MIC) of copaiba emulsions against microorganisms.
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In recent studies, a zymography assay was performed with HT1080 cells. This 
demonstrated that the copaiba oil emulsion (CO) as dentin biomodifier showed the 
potential to inhibit matrix metalloproteinases −2 and −9 (Figure 1).
In the time of 30 seconds, statistical difference in the decrease of the MMP-9 activ-
ity was observed among all solutions tested when compared with the control group 
without treatment. In the time of 10 minutes, there was a statistical difference only 
between chlorhexidine (CLX), 10% CO + 0.3% CV, and 10% alkaline CO. At 20 min-
utes, the only solution that presented a statistical difference in the decrease of MMP-9 
activity was the 10% CO + 0.3% CV. The best result obtained was with 10% alkaline 
CO in a time of 10 minutes, with a 35% decrease in MMP-9 activity (Figure 2A).
A decrease in the MMP-2 enzymatic activity was also observed. At 30 seconds, 
there was a statistical difference between the CLX solution and the copaiba oil 
emulsion at 0, when compared to the control group. At 10 minutes, a statistical 
difference was observed in the CLX solution and the alkaline CO, each presenting a 
44 and 67% reduction in enzyme activity, respectively. Finally, at 20 minutes, there 
was a statistical difference in the CLX solution (21%), in the COs 0.3% (42%) and 
0.6% (53%), and in the alkaline CO (Figure 2B).
Figure 2. 
Anti-proteolytic activity of the copaiba oil emulsions on (A) MMP-9 and (B) MMP-2.
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Figure 3. 
Photomicrograph of the group (A) without dentin surface treatment, (B) air/water spray treatment,  
(C) chlorhexidine, and (D) copaiba oil emulsion treatments.
2.3 Influence of copaiba oil emulsions as dentin surface biomodifiers
Bandeira et al. [5] used scanning electron microscopy (SEM) to investigate the 
morphology of the dentin surface, cut and treated with CO and ethanolic extract of 
propolis, with the aim of using them as bioactive agents for cleaning teeth. For the 
formulations of 10% CO, 10% CO + PB, 30% CO, and 30% CO + PA emulsions, the 
same cleaning pattern was obtained as that obtained with 2% chlorhexidine, which 
is considered the gold standard, because it had substantivity and showed bacterio-
static and bactericidal activities (Figure 3).
The bond of polymer-based materials to dentin is still considered a significant 
challenge because the latter is a complex substrate, predominantly tubular, and 
intrinsically moist. The use of disinfectant and anti-proteolytic solutions may be 
an alternative for reducing these effects. In a histological evaluation, 10% CO was 
used on the exposed collagen of the dentin matrix, with the purpose of verify-
ing whether there was interference in the adhesive system. Thus, 80 specimens 
(CPs) were prepared from healthy third molars, and after the induction of caries 
lesions, the specimens were treated with test materials for 3 months of aging. The 
CPs treated with the copaiba emulsions presented higher exposed and hybridized 
collagen thickness values than the groups treated with CLX 2% and AD. Relative to 
caries-affected dentin, the group treated with CLX 2% showed a higher proportion 
of CPs with hybridized collagen. The emulsion presented 100% specimens with 
hybridized collagen and improved hybrid layer homogeneity (Figure 4).
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Given the biological properties of C. multijuga Hayne, a copaiba oil emulsion was 
formulated for use before applying the adhesive to improve the quality of dentin 
bonding. The morphological characteristics of the dentin surface and the hybrid 
layer formed with etch-and-rinse and self-etching adhesive systems in healthy and 
caries-affected dentin after using the 10% copaiba oil emulsion were analyzed. A 
total of 96 third molars from Biobank of the School of Dentistry, Federal University 
of Amazonas (FAO-UFAM), were used. Half of the teeth underwent artificial 
induction of dental caries and the other half formed the group of healthy teeth. 
The roots of all the teeth were removed, yielding dentine disks that were divided 
into groups according to test substances (CLX 2%, copaiba oil emulsion, calcium 
hydroxide solution, and distilled water), the dentin (sound or caries-affected), and 
the adhesive system (Adper Single Bond 2® and Clearfil SE Bond®).
SEM was used to analyze the dentin surface and hybrid layer of the specimens 
obtained, according to the experimental groups. The dentin surface treatment with 
copaiba oil emulsion showed no physical barrier to adhesive penetration. The dentin 
surface treated with 2% chlorhexidine showed phosphate salts in two types of dentin. 
Dentin surface treatment with calcium hydroxide solution resulted in the deposi-
tion of mineral precipitate obstructing the lumen of the tubules in sound dentin. 
The result of calcium hydroxide solution applied on the conditioned sound dentin 
differed from those of the other substances (p < 0.05). On the smear layer surface, 
the result of distilled water on sound dentin showed a significant difference from 
the results of all experimental groups (p < 0.05). There was no statistical difference 
between the hybrid layer formed with the Single Bond® adhesive in otherwise healthy 
dentin specimens and those of caries-affected dentin treated with the test substances.
In the dentin-rich and caries-affected dentin treated with CLX 2%, the hybrid 
layer formed with Adper Single Bond® was thick, regular, and homogeneous, with 
long resin tags, but in smaller quantity than those in the distilled water group. The 
hybrid layer formed with Clearfil SE Bond® on the dentin treated with CLX showed 
few irregular resin tags with little adhesive infiltration into the dentin (Figure 5).
The hybrid layer formed with the Clearfil SE Bond® adhesive on the caries-
affected dentin and caries-affected dentin treated with the copaiba oil-based 
emulsion presented regular and homogeneous hybrid layer with a large number of 
resin tags (Figure 6).
The CO application showed no morphological change in sound and caries-
affected dentin, irrespective of phosphoric acid etching, and presented a uniform 
hybrid layer, regular, and extensive monomer infiltration into sound and caries-
affected dentin, irrespective of the adhesive system.
Figure 4. 
Hybrid dentin specimen stained with Goldner’s Trichrome. (A) Chlorhexidine treatment and (B) copaiba oil 
emulsion treatment; (a) hybridized collagen, (b) mineralized dentin, (c) adhesive.
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Figure 6. 
Hybrid layer formed with Single Bond in dentin treated with copaiba oil: (A) healthy dentin and (B) caries-
affected dentin. Hybrid layer formed with Clearfil in dentin treated with copaiba oil: (C) healthy dentin and 
(B) caries-affected dentin. (a) adhesive, (d) dentin, and (CH) hybrid layer. The arrows point to the resin tags.
Figure 5. 
Hybrid layer formed with Single Bond in the dentin treated with chlorhexidine: (A) Healthy dentin and (B) caries-
affected dentin. Hybrid layer formed with Clearfil on the dentin treated with chlorhexidine: (C) Healthy dentin 
and (D) caries-affected dentin. (a) Adhesive, (d) Dentin, (CH) Hybrid layer. The arrows point to the resin tags.
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The hybrid layer formed with Adper Single Bond® in the carious-affected and 
caries-affected dentin treated with copaiba oil-based emulsion was thick, regular, and 
homogeneous, with long resin tags, but in smaller quantity than those in the distilled 
water group (Figure 6).
Thus, the copaiba oil emulsion as dentin biomodifiers with their antibacterial 
activity and property of inhibiting MMPs may contribute to stability of the hybrid 
layer, perhaps because they prevent the enzymatic hydrolysis of collagen due to 
their oily nature similar to that of mineral oil. Further studies must be conducted 
to show the mechanism of action of the oil on the MMPs and the formation of the 
hybrid layer. In the present work, it was shown that the MMPs were resistant to the 
time-dependent destruction of the hybrid layer and that the use of inhibitors could 
improve the durability of the composite resin-dentin bond [35].
3. Apis mellifera—Propolis
Propolis is a resinous substance, collected and transformed by the Apis mellifera 
bees, used in the hives as sealant. The vegetation, climate, and other factors influ-
ence the characteristics and composition of the propolis of each region. Studies have 
shown that propolis is composed of more than 300 (three hundred) substances, 
among them the most important are flavonoids and their phenolic compounds. Its 
biological properties include anticancer, antioxidant, anti-inflammatory, antibiotic, 
and antifungal activities [12, 13].
Worker bees of the A. mellifera species remove propolis from the shoots and 
resinous secretions present in the trees. By using their jaws and their legs, they mix 
these secretions with the wax synthesized by them. The mandibular glands of the 
workers secrete 10-hydroxydecanoic acid, which enables the finishing of propolis. 
Factors such as plant ecology of the region where the propolis was collected and 
even the genetic variability of the queens also influence the chemical composi-
tion of propolis. According to CONAPIS (information body of CONAP, National 
Council of Apiculture Ltda.), the ideal propolis is the type produced in regions 
where there is as little environmental pollution as possible, away from urban centers 
and factories that emit pollutants [14].
Almeida et al. [15] reported that propolis is a complex mixture of resinous, 
gummy, and balmy substances collected by A. mellifera bees. It has a bactericide, 
antimicrobial, antioxidant, anti-inflammatory, immunomodulatory, hypoten-
sive, anesthetic, anti-cancerous, anti-HIV, and anti-carious biologic function. 
These biological activities are related to their chemical components present in the 
propolis of the Amazon region.
Ishida et al. [14] analyzed the ethanolic propolis extracts from four propolis 
samples (E1–E4) from Manaus (Brazilian Amazon) by HPLC/DAD/ESI–MS/MS 
and GC/EIMS. The main components of E2 and E4 were polyprenylated benzo-
phenones: 7-epi-nemorosone, 7-epi-clusianone (major E4 constituents), xan-
thochymol, and gambogenone (major E2 constituents), making up a chemical 
profile so far unreported for Brazilian propolis. Aristhophenone, methyl insigni-
none, 18-ethyloxy-17-hydroxy-17, 18-dihydroscrobiculatone B, and derivatives 
of dimethyl weddellianone A and B, propolones, and a scrobiculatone derivative 
were detected as minor constituents. Triterpenoids (b-amyrins, b-amyrenone, 
lupeol, and lupenone) were ubiquitous and predominant in E1 and E3. The 
extracts E2 and E4 were highly active against the cariogenic bacteria S. mitis, S. 
mutans, and S. salivarius. E2 was more active than E4, probably due to a higher 
content of 2-epi-nemorosone, while the latter was more abundant in dihydroxyl-
ated compounds.
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By histological analysis of the extracts in subcutaneous connective tissue in rats, a 
propolis solution for cavity cleansing and its toxicity was investigated through hemo-
lytic and Artemia franciscana tests. Fifteen male rats were selected and randomly 
distributed into three experimental time intervals (07, 30, and 45 days), in which 
each animal received the four groups of treatment in rounds: Group I, Propolis I; 
Group II, Propolis II; Group III, calcium hydroxide water; and Group IV, 2% CLX; 
the sides of the tube were the control group. As regards biocompatibility, the results 
showed that all materials presented a significant reduction in inflammatory infiltrate 
and an increase in collagen fiber thickness values (Figure 7). In decreasing order 
of biocompatibility, the use of the following materials may be suggested: calcium 
hydroxide-water, 2% chlorhexidine®, Propolis I, and Propolis II. In the cytotoxicity 
test using Artemia franciscana, the propolis extract showed high toxicity in the tested 
concentrations, and in the hemolytic activity test, the Propolis I extract showed 
more activity than Propolis II. Therefore, the present study suggested the use of 
propolis as a cavity cleansing solution for shallow and medium cavities similarly to 
the use of 2% chlorhexidine® [15].
In continuing studies of the application of biomaterials in dentistry, the 
response of inflammatory periodontal disease (PD) induced in rat periodontal 
tissue was histologically evaluated after the use of 0.1, 1, and 10% aqueous suspen-
sions of propolis (SAP) for subgingival irrigation. A total of 84 Wistar rats (Rattus 
norvegicus) were distributed into the following experimental groups: Group I 
(n = 14, 0.1% SAP), Group II (n = 14, 1% SAP), Group III (n = 14, 10% SAP), Group 
IV (n = 14, 5% Tween 80 solution), Group V (positive control, n = 14, with induced 
and untreated PD), Group VII (n = 14, 2% CLX), and Group VI (n = 84, negative 
control, non-induced and unprocessed contralateral teeth of Groups I, II, III, IV, 
V, and VII). After induction of PD by the ligation technique in the cervical portion 
of the mandibular left first molar for 15 days, the periodontal pocket was irrigated 
three times (first, fourth, and seventh days). The animals were sacrificed at 15 
and 30 days after the treatment. The results suggested that SAP demonstrated an 
effective inflammatory response in the short term (15 days) and in the concentra-
tion of 0.1% was associated with the presence of dense gingival fibers, blood vessels 
Figure 7. 
(A) Anatomical shape of rat molar (H.E. 40x): (RM) mesial root, (RD) distal root, (F) furca, (GM) mesial 
gingiva, and (GD) interproximal gingiva. (B) Furcation region of the tooth treated with aqueous suspension 
of 0.1% propolis at 30 days (H.E. 200x): (E) epithelium of the exocytosis purse-string, (F) moderate collagen 
fibers, (O) bone tissue, and (arrow) moderate, chronic, and focal inflammatory infiltrate.
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without congestion, absence of dental resorption and bone loss, and may be an 
alternative treatment of PD. However, future studies are required to demonstrate 
the biological feasibility of the use of propolis as an adjuvant to periodontal therapy.
4. Libidibia ferrea
4.1 Plant species and its applicability
Among the vast biodiversity of medicinal plants, Libidibia ferrea—popularly 
referred to as Jucá or ironwood—is another plant from the Brazilian biome noted for 
several therapeutic properties [20]. Characterized as belonging to the Leguminosae 
family tree, its scientific name is Libidibia ferrea (Mart. ex Tul.) L.P.Queiroz var. ferrea, 
ex Caesalpinia ferrea Mart. ex Tul. (International Plant Names Index, 2009) [36].
The fruits (pods) of this species are used for the treatment of diabetes and can-
cer prevention, in addition to wound healing [37]; the roots have been documented 
as having antipyretic effects, being used in the treatment of diarrhea, and having 
anticancer properties [38, 39]; and the bark has been used for treatment of entero-
colitis and rheumatism [40]. Therefore, these parts of this species have shown anti-
inflammatory [36], antifungal [19], antihistaminic, antiallergic, anticoagulant [41], 
antiproliferative, cytoprotective, and antimutagenic effects [42]. Furthermore, 
L. ferrea has been used for biosynthesis of silver nanoparticles (AgNPs), thereby 
preserving its antimicrobial activity, reducing its toxic effects on human cell lines 
and increasing its practical use without the impact on the environment. AgNPs are 
one of the most important nanomaterials among several metallic nanoparticles that 
are involved in biomedical applications [23].
In dentistry, L. ferrea has demonstrated potential antibacterial activity against 
oral microorganisms [20, 21], in addition to anti-inflammatory and analgesic prop-
erties [41, 43]. Nevertheless, several tests are still necessary to improve new dental 
products and prove their efficacy when used in the oral cavity, with the aim of using 
them in the dental clinic.
4.2 Preliminary studies—standardization of the extract
Initially, taking into consideration the vast biodiversity of medicinal plants of 
the Amazon region (Brazil), which have been used empirically due to their antibac-
terial action, these species have been screened with regard to their antimicrobial 
activity against microorganisms isolated from dental biofilm [44].
Since the research began, there has been constant concern to ensure the legiti-
macy of plant species used to obtain the study extracts. The species were collected 
from official research institutions (Brazilian Agricultural Research Corporation, 
EMBRAPA; Federal University of Amazonas, UFAM; and Brazilian Institute of 
Environment and Renewable Natural Resources, IBAMA) and were stored at the 
Lauro Pires Xavier Herbarium in the Systematic and Ecology Department/Federal 
University of Paraíba, according to the Genetic Heritage Component Sample Access 
and Delivery Authorization (No. 044/2004–IBAMA/MMA). From this initial 
screening, both L. ferrea and C. multijuga extracts exhibited antimicrobial activity 
against S. sobrinus, S. mutans, S. mitis, S. sanguis, and Lactobacillus casei strains and 
inhibited microbial adherence of these tested strains (Table 2) [44].
Sequentially, studies have shown L. ferrea fruit extract inhibited the in vitro 
growth of the following oral pathogens (C. albicans, S. mutans, S. salivarius,  
S. oralis, and L. casei) on planktonic cells and multispecies biofilm models, sup-
porting the use of this extract for the treatment of oral infections [19]. On the other 
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hand, L. ferrea stem bark extract exhibited better antimicrobial activity than fruit 
extract when tested against the same oral microorganisms in planktonic cells [45].
Dental biofilm is a dense, whitish, noncalcified aggregate of bacteria, with 
desquamated epithelial cells and food debris creating conditions for an imbalance 
of resident oral microflora, favoring the destruction of hard and soft tissues by the 
development of oral pathologies such as caries and gingivitis. Recently, an L. ferrea 
extract was standardized according to the current Brazilian legislation with regard 
to pH, sedimentation, density, and stability, along with microbiological tests of the 
extract. The microbial test was used to verify the presence of Staphylococcus aureus, 
Pseudomonas aeruginosa, fungi, yeasts, coliforms, and minimum inhibitory concen-
trations of S. mutans and S. oralis strains. Thus, this L. ferrea extract was shown to 
have antibacterial activity against the oral microorganisms tested and satisfactory 
stability and quality, enabling the formulation of a mouthwash using this extract to 
control dental biofilm [20].
4.3 Standardization of the orabase and mouthwash formulations
After the preliminary studies of the L. ferrea extract, orabase and mouthwashes 
based on this extract were analyzed.
The use of oral antimicrobial formulations as an adjunct treatment to mechani-
cal means of dental biofilm and gingival inflammation control has been well 
established [46]. However, acceptance of the use of plant-based oral products still 
faces obstacles due to a lack of quality control, since the profile of the end-product 
constituents has implications in phytotherapeutic efficiency and safety [47]. Thus, 
the Brazilian ANVISA [48] has established that all phytotherapeutic medication 
must be submitted to formulation stability tests. Production operations must follow 
operational procedures with clearly defined and approved standards, in conformity 
with the notification or registration of traditional phytotherapeutic products with 
the competent sanitary agency. The final objective is to obtain products that are 
within the quality standards demanded.
Therefore, Marreiro et al. [20], in a preliminary study, evaluated the antimicro-
bial activity of aqueous extracts of the fruits, stem bark, and an orabase formulation 
of L. ferrea against biofilm microorganisms by the agar diffusion and broth micro-
dilution methods and evaluated cytotoxicity by hemolysis assay on fibroblast cell 
Microorganisms
Tested substances/MIC S. 
mutans
S. 
mitis
S. 
sanguis
S. 
sobrinus
L. 
casei
L. ferrea (Jucá) 1:8 (62.5 mg/mL) 15 14 14 15 15
A. chica (Crajiru) (500 mg/mL) 0 0 0 13 13
O. micranthum (alfavaca) (1000 mg/mL) 0 0 16 12 0
C. multijuga (copaíba) (1000 mg/mL) 20 19 19 20 22
Chlorhexidine 0.12% 1:8 (0.15 mg/mL) 12 13 13 12 13
A. nitidum (carapanaúba) 0 0 0 0 0
C. guianensis (andiroba) 0 0 0 0 0
E. ayapana (Japana-branca) 0 0 0 0 0
S. acmella (jambu) 0 0 0 0 0
Table 2. 
Diameter of the inhibition halos (mm) of the substances against the microorganisms.
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culture. This study endeavored to find an alternative material as a way to guarantee 
the supply of raw vegetable matter independent of the seasonality of the fruits. The 
microorganisms used for determining the MICs were S. salivarius, S. mutans, S. oralis, 
L. casei, and C. albicans. The extract of the stem bark and the orabase formulation of 
L. ferrea showed antimicrobial activity against microorganisms of the biofilm and 
were not toxic when tested on erythrocytes and in cell cultures (Figure 8).
In addition to these results, Venâncio et al. [21] evaluated the in vitro pharma-
cological stability of a phytotherapeutic mouthwash based on L. ferrea extract with 
regard to the microbiological parameters of control, organoleptic characteristics, 
sedimentation, pH, and density. Using methods in accordance with the legislation, the 
study determined the total number of microorganisms and Salmonella sp., Escherichia 
coli, Pseudomonas aeruginosa, and Staphylococcus aureus; stability characteristics (color, 
odor, brightness, and consistency); sedimentation test (centrifuge); the pH measure-
ment (pH meter); and density evaluation (pycnometer). The results demonstrated 
the L. ferrea mouthwash was shown to be free of contamination for the tested micro-
organisms and was within the standards of safety demanded for its use.
In addition to the reported studies, with the aim of finding another purpose for 
its use, Matos [49] evaluated a formulation of L. ferrea orabase for use in the healing 
of oral ulcers. The overall aim of this study was the physical-chemical quality control 
of an orabase ointment formulation of L. ferrea. For physicochemical evaluation, 
centrifugal tests, pH, mass, relative density, microbiological assessment, and organo-
leptic character of contaminant tests were performed. The physical conditions tested 
were storage at room temperature (±25.9°C), room temperature, protected from light 
(±28.8°C), and air conditioning (±23.7°C); the experimental time intervals were 0, 30, 
and 60 days. The results showed that in the centrifugation test, phase separation was 
observed at all times and in all storage environments. In the pH test, only the formula-
tion stored at room temperature obtained a lower pH value, mean (1.95) after 60 days 
of manipulation. The density test showed the mean value of 0.809 g/cm3 when tested 
at time 0 and after 30 days of formulation values under air conditioning (0.746 g/cm3), 
room temperature (0.702 g/cm3), and room temperature, protected from light, dark 
(1.022 g/cm3). The evaluation of contaminants showed that there was no bacterial 
growth in any environment and experimental time, but macroscopically, the increase 
in cotton wool colonies compatible with fungal colonies was observed in the formula-
tion stored under air conditioning in the time interval of 30 days and under all storage 
locations in the time interval of 60 days. In the organoleptic assessment, the ointment 
showed changes at 60 days after formulation. Based on the results, the formulation 
tested maintained the best stability of the tested characteristics when stored at room 
temperature in the dark. However, after 60 days of storage, the formulation presented 
chemical and physical instability and growth of contaminants.
Figure 8. 
Hemolysis assay: Triton™ X-100 (positive control). *** Statistically significant in comparison with the positive 
control (P < 0.05).
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5. Conclusions
Given the growth of the products derived from medicinal plants in Brazil, it was 
necessary to implement a statute that covered the requirements for all medicines 
and biomaterials to ensure the quality, efficacy, and safety of these products. Based 
on the researches, C. multijuga, in the form of copaiba oil, was an effective agent 
against the etiological agents of caries disease. Copaiba oil emulsions as dentin 
biomodifiers with their properties of antibacterial activity and inhibition of MMPs 
may contribute to the stability of the hybrid layer in caries-affected dentin treated 
with this emulsion.
Propolis demonstrated an effective and controlled inflammatory response in 
the periodontal tissue such as the absence of bone resorption, blood vessels without 
congestion, and presence of dense gingival fibers.
The L. ferrea extract showed antibacterial activity against the oral microor-
ganisms tested, and satisfactory stability and quality, enabling the formulation 
of a mouthwash using this extract to control dental biofilm. The results dem-
onstrated that the L. ferrea mouthwash was shown to be free of contamination 
for the tested microorganisms and was within the standards of safety demanded 
for/to allow its use.
As propolis showed a reduction in bone resorption, and the other medicinal 
plants studied were in compliance with the safety standards, future investiga-
tions into the effectiveness of adding these herbal medicines to bone substitutes 
will be conducted. Via an effective biodegradation delivery system, the release 
of phytotherapic agents is expected to promote the growth of bone tissue. 
Pharmacological tests will examine the phytotherapic ability to generate an 
osteotropic effect, stimulating bone cell proliferation and differentiation while 
decreasing osteoclast activity. Thus, future studies will be in search of herbal 
devices that stimulate the innate regenerative capacity of bone and can be used in 
the regeneration of bone tissue.
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